논문 및 학회자료

Safety evaluation of FM101, an A3 adenosine receptor modulator, in rat, for developing as therapeutics of glaucoma and hepatitis. EXCLI Journal. 2020

Admin │ 2021-03-07

HIT

648

이전글 1
다음글 1